Botanical species · safety record

Roemeria refracta

The EFSA Compendium of Botanicals holds 14 constituent measurements for Roemeria refracta. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Roemeria refracta DC.

14Constituent measurements
0Safety records
7Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Isoquinoline alkaloids4
  • Anonaine1
  • Armepavine1
  • Coclaurine1
  • Ephedrine1
  • Flavinantine1
  • Liriodenine1
  • N-methylcoclaurine1
  • Opium alkaloids1
  • Pseudoephedrine1

Plant parts

  • Unspecified9
  • Aerial part of plants3
  • Live plants2

Preparations

  • Solvent extraction14

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
ArmepavineUnspecifiedSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
CoclaurineUnspecifiedSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
FlavinantineUnspecifiedSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
Isoquinoline alkaloidsUnspecifiedSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
Isoquinoline alkaloidsUnspecifiedSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
Isoquinoline alkaloidsUnspecifiedSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
N-methylcoclaurineUnspecifiedSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
Opium alkaloidsUnspecifiedSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
AnonaineAerial part of plantsSolvent extraction——No resolvable identifier
EphedrineLive plantsSolvent extraction——No resolvable identifier
Isoquinoline alkaloidsAerial part of plantsSolvent extraction——No resolvable identifier
LiriodenineAerial part of plantsSolvent extraction——No resolvable identifier
PseudoephedrineLive plantsSolvent extraction——No resolvable identifier
RoemerineUnspecifiedSolvent extraction0.11 Percent—No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Yunusov, M. S., Akramov, S. T., Yunusov, S. Yu. Alkaloids of Roemeria refracta. Doklady akademii nauk uzssr, 1966, vol. 23, no. 5, p. 38-40.
  2. Konovalova, R. A., Yunusov, S., Orekhov, A. P. Alkaloids of papaveraceous plants. IV. Alkaloids of Roemeria refracta D. C. Constitution of remerine and synthesis of 2,3-methylenedioxyphenanthrene. Zhurnal obshchei khimii, 1939, vol. 9, p. 1507-11.
  3. Shakirov, T. T., Aripov, Kh. N., Yunusov, S. Yu. Isolation of roemerine using ion-exchange resins. Khimiya prirodnykh soedinenii, 1968, vol. 4, no. 6, p. 394.
  4. GOZLER, B., GOZLER, T., FREYER, AJ., SHAMMA, M. SOME UNUSUAL PAVINE AND ISOPAVINE ALKALOIDS FROM ROEMERIA-REFRACTA. Journal of natural products, 1988, vol. 51, no. 4, p. 760-764. DOI
  5. GOZLER, B., KIVCAK, B., GOZLER, T., SHAMMA, M. 2 NEW BENZYLTETRAHYDROISOQUINOLINE ALKALOIDS FROM ROEMERIA-REFRACTA. Journal of natural products, 1990, vol. 53, no. 3, p. 666-668. DOI
  6. GOZLER, B., OZIC, P., FREYER, AJ., SHAMMA, M. MORPHINANDIENONE ALKALOIDS FROM ROEMERIA-REFRACTA. Journal of natural products, 1990, vol. 53, no. 4, p. 986-988. DOI
  7. GOZLER, B., ONUR, MA., BILIR, S., HESSE, M. EPIMERIC ISOPAVINE N-OXIDES FROM ROEMERIA-REFRACTA. Helvetica chimica acta, 1992, vol. 75, no. 1, p. 260-268. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue